少妇精品在线_国产欧美一区二区三区四区五区|HD中文字幕在线播放,男生和女生鸡鸡对鸡鸡,性欧美xxxxsss,国产99久久精品一区二区

科學文獻

我們與學術機構開展合作研究，以評估我們的管線產品。以下是發表的相關文獻。

年：

Adjusted comparison of outcomes between patients from CARTITUDE-1 versus multiple myeloma patients with prior exposure to PI, IMiD and anti-CD38 antibody from the prospective, multinational LocoMMotion study of real-world clinical practice

MV Mateos, K Weisel, T Martin, JG. Berdeja, A Jakubowia […]

Five?year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR?B38M chimeric antigen receptor T cells in the LEGEND?2 study: a case report

BY Wang, WH Zhao, YX Chen, XM Cao, Y Yang, YL Zhang, FX […]

Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice

Delforge M, Vekemans M, Depaus J, Meuleman N, Van De Ve […]

Updated results from a matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma

Tom Martin, Saad Z. Usmani, Jordan M. Schecter, Tito Ro […]

Patient Perceptions Regarding Ciltacabtagene Autoleucel Treatment: Qualitative Evidence From Interviews With Patients With Relapsed/Refractory Multiple Myeloma in the CARTITUDE-1 Study

Adam D. Cohen, Parameswaran Hari, Myo Htut, Jesus G. Be […]

本網站使用Cookies來改善您的整體體驗，讓您下次訪問網站時更加輕松快捷，為您帶來更好的服務。具體內容請參閱隱私政策 Cookie政策。